TABLE 3.
NEFA(0)-LDL | NEFA(0.5)-LDL | NEFA(1.5)-LDL | LDL(-) | |
---|---|---|---|---|
NEFA content | 20.4 ± 6.44 | 47.4 ± 6.34* | 70.8 ± 27.4* | 55.92 ± 7.35 |
MCP1 | 0.96 ± 0.55 | 1.2 ± 0.70* | 1.38 ± 0.61* | 2.58±1.04 |
IL6 | 0.54 ± 0.13 | 0.69 ± 0.46 | 0.82 ± 0.40* | 1.52 ± 0.38 |
IL8 | 5.99 ± 1.41 | 6.80 ± 2.44 | 9.34 ± 3.06* | 12.57 ± 5.87 |
IL10 | 0.18 ± 0.09 | 0.26 ± 0.20 | 0.38 ± 0.31* | 0.61 ± 0.173 |
NEFA concentration in the incubation with LDL is expressed as mM in parentheses. Final NEFA content in LDL is expressed as μmol NEFA/g apoB and cytokine release as ng/106 cells (n = 6). Data of LDL(–), including NEFA content and cytokine release, are extracted from results of Fig. 1 and 3A. Significant differences with P < 0.05 versus NEFA(0)-LDL are indicated with *.